13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$1.08T
+13% on the quarter before
Positions
4,609
133 new · 176 sold out
Top 10
27.5%
of the value
Est. gain
+$90.89B
on stocks held all quarter
Est. return
+9.5%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 38% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$2.25BAdded · 2.6% → 4.4%+2,499,701 shares
- Microsoft~$1.39BAdded · 6.1% → 6.1%+3,317,402 shares
- Amazon~$1.26BAdded · 2.9% → 3.1%+7,004,185 shares
- Apple~$1.18BAdded · 6.0% → 4.9%+6,898,229 shares
- Corpay Inc~$505.5MNew · 0.0% → 0.0%+1,642,580 shares
- Alphabet~$505.3MAdded · 1.8% → 1.8%+3,355,978 shares
- Super Micro~$486.1MAdded · 0.0% → 0.1%+482,040 shares
- Berkshire Hathaway Inc-Cl B~$483.8MAdded · 1.3% → 1.4%+1,153,113 shares
- Eli Lilly~$480.7MAdded · 1.0% → 1.2%+619,557 shares
- Cooper Cos Inc/The~$471.6MNew · 0.0% → 0.0%+4,659,350 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Fleetcor Technologies Inc~$451.2MSold out · 0.0% → 0.0%−1,600,609 shares
- Cooper Cos Inc/The~$425.1MSold out · 0.0% → 0.0%−1,126,226 shares
- Splunk Inc~$373.2MSold out · 0.0% → 0.0%−2,453,284 shares
- Amgen Inc~$197.6MCut · 0.4% → 0.3%−696,648 shares
- Karuna Therapeutics Inc~$180.4MSold out · 0.0% → 0.0%−569,722 shares
- Immunogen Inc~$159.6MSold out · 0.0% → 0.0%−5,382,875 shares
- General Motors Co~$121.0MCut · 0.1% → 0.1%−2,676,762 shares
- Spirit Realty Capital Inc~$108.8MSold out · 0.0% → 0.0%−2,490,658 shares
- Aon Plc-Class A~$96.9MCut · 0.1% → 0.1%−291,213 shares
- Rtx Corp~$80.9MCut · 0.2% → 0.2%−832,168 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +2.2% · price +11.9% | 6.1% | $66.15B | +$6.89B | ||||||||
| AppleCOM · shares +2.3% · price −10.9% | 4.9% | $52.65B | −$6.30B | ||||||||
| NvidiaCOM · shares +5.0% · price +82.5% | 4.4% | $47.32B | +$20.37B | ||||||||
| AmazonCOM · shares +3.9% · price +18.7% | 3.1% | $33.79B | +$5.13B | ||||||||
| MetaCL A · shares +1.1% · price +37.2% | 2.1% | $22.48B | +$6.03B | ||||||||
| AlphabetCAP STK CL A · shares +2.7% · price +8.1% | 1.8% | $19.44B | +$1.41B | ||||||||
| AlphabetCAP STK CL C · shares +2.1% · price +8.0% | 1.4% | $15.49B | +$1.13B | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +3.4% · price +17.9% | 1.4% | $14.82B | +$2.18B | ||||||||
| Eli LillyCOM · shares +3.9% · price +33.5% | 1.2% | $12.86B | +$3.11B | ||||||||
| BroadcomCOM · shares +1.8% · price +18.7% | 1.2% | $12.59B | +$1.95B | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.9% · price +17.7% | 1.1% | $11.37B | +$1.67B | ||||||||
| TeslaCOM · shares +3.0% · price −29.2% | 0.92% | $9.98B | −$4.00B | ||||||||
| Visa Inc.COM CL A · shares +2.5% · price +7.2% | 0.90% | $9.71B | +$639.0M | ||||||||
| Unitedhealth Group IncCOM · shares +4.0% · price −6.0% | 0.86% | $9.35B | −$577.2M | ||||||||
| Exxon Mobil CorpCOM · shares +3.0% · price +16.3% | 0.85% | $9.14B | +$1.24B | ||||||||
| Johnson & JohnsonCOM · shares +4.0% · price +0.9% | 0.78% | $8.42B | +$74.9M | ||||||||
| MastercardCL A · shares +2.0% · price +12.9% | 0.78% | $8.39B | +$940.9M | ||||||||
| Procter & Gamble Co/TheCOM · shares +4.1% · price +10.8% | 0.73% | $7.93B | +$741.5M | ||||||||
| Home Depot IncCOM · shares +3.5% · price +10.7% | 0.73% | $7.92B | +$741.1M | ||||||||
| Merck & Co. Inc.COM · shares +1.8% · price +21.0% | 0.69% | $7.43B | +$1.27B | ||||||||
| Abbvie IncCOM · shares +1.3% · price +17.5% | 0.63% | $6.81B | +$1.00B | ||||||||
| Costco Wholesale CorpCOM · shares +3.5% · price +11.0% | 0.61% | $6.64B | +$635.9M | ||||||||
| AMDCOM · shares +3.2% · price +22.5% | 0.55% | $5.90B | +$1.05B | ||||||||
| SalesforceCOM · shares +2.8% · price +14.5% | 0.53% | $5.71B | +$703.6M | ||||||||
| Chevron CorpCOM · shares +2.3% · price +5.8% | 0.51% | $5.57B | +$298.7M | ||||||||
| Total · 4,609 positions | 100% | $1.08T | +$90.89B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 4,474 stocks held throughout, up $90.89B (+9.5%).
- Nvidia+$20.37B+83%
- Microsoft+$6.89B+12%
- Meta+$6.03B+37%
- Amazon+$5.13B+19%
- Eli Lilly+$3.11B+33%
- Unitedhealth Group Inc−$577.2M−6%
- Boeing Co/The−$720.6M−26%
- Adobe−$907.8M−15%
- Tesla−$4.00B−29%
- Apple−$6.30B−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 8 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |